Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 USD | -2.00% | -1.29% | -15.93% |
12:32pm | Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M | MT |
Mar. 18 | Aspira Women's Health Inc. Announces Executive Changes | CI |
Financials (USD)
Sales 2023 * | 9.58M | Sales 2024 * | 14.2M | Capitalization | 40.16M |
---|---|---|---|---|---|
Net income 2023 * | -17M | Net income 2024 * | -16M | EV / Sales 2023 * | 4.19 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 2.83 x |
P/E ratio 2023 * |
-1.79
x | P/E ratio 2024 * |
-2.46
x | Employees | 85 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 57.54% |
Latest transcript on Aspira Women's Health Inc.
1 day | -2.00% | ||
1 week | -1.29% | ||
Current month | -13.16% | ||
1 month | -15.31% | ||
3 months | -9.02% | ||
6 months | -36.83% | ||
Current year | -15.93% |
Managers | Title | Age | Since |
---|---|---|---|
Nicole Sandford
CEO | Chief Executive Officer | 54 | 21-02-21 |
Torsten Hombeck
DFI | Director of Finance/CFO | 55 | 23-06-14 |
Tatiana Black
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ellen Vos
BRD | Director/Board Member | 68 | 23-05-08 |
Director/Board Member | 60 | 23-05-08 | |
Jannie Herchuk
CHM | Chairman | - | 23-05-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 3.43 | -2.00% | 24,759 |
24-03-26 | 3.5 | -1.69% | 21,458 |
24-03-25 | 3.56 | -2.47% | 19,172 |
24-03-22 | 3.65 | +1.11% | 14,010 |
24-03-21 | 3.61 | +3.88% | 52,109 |
Delayed Quote Nasdaq, March 27, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.93% | 40.16M | |
-9.60% | 12.14B | |
+73.43% | 3.94B | |
-33.60% | 2.19B | |
-21.05% | 1.63B | |
+30.99% | 1.14B | |
+9.17% | 852M | |
-12.33% | 545M | |
-41.02% | 419M | |
+28.48% | 249M |